References
- Lopez AD, Shibuya K, Rao C et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 27(2), 397–412 (2006).
- Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859), 2095–2128 (2012).
- Kim V, Han MK, Vance GB et al.; COPDGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 140(3), 626–633 (2011).
- Tashkin DP, Celli B, Senn S et al.; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 359(15), 1543–1554 (2008).
- Calverley PM, Anderson JA, Celli B et al.; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 356(8), 775–789 (2007).
- Oba Y, Lone NA. Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ther. Adv. Respir. Dis. 7(1), 13–24 (2013).
- Antoniu SA. Roflumilast: a new anti-inflammatory therapy in chronic obstructive pulmonary disease. Hot Top. Respir. Med. 20(1), 17–20 (2012).
- Rennard SI, Calverley PM, Goehring UM, Bredenbröker D, Martinez FJ. Reduction of exacerbations by the PDE4 inhibitor roflumilast–the importance of defining different subsets of patients with COPD. Respir. Res. 12, 18 (2011).
- Wedzicha JA, Rabe KF, Martinez FJ et al. Efficacy of roflumilast in the COPD frequent exacerbator phenotype. Chest 143(5), 1302–1311 (2013).
- Samyshkin Y, Kotchie RW, Mörk AC, Briggs AH, Bateman ED. Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom. Eur. J. Health Econ. (2013).
- Miravitlles M, Soler-Cataluña JJ, Calle M et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim. Care Respir. J. 22(1), 117–121 (2013).